Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF – Get Free Report) saw a significant drop in short interest in the month of July. As of July 15th, there was short interest totaling 25,239 shares, a drop of 50.1% from the June 30th total of 50,577 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.
Kissei Pharmaceutical Stock Performance
Shares of KSPHF remained flat at $25.77 during mid-day trading on Tuesday. Kissei Pharmaceutical has a twelve month low of $23.23 and a twelve month high of $31.90. The stock’s fifty day simple moving average is $25.77 and its 200 day simple moving average is $26.17.
About Kissei Pharmaceutical
Kissei Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company that specializes in the research, development and manufacture of prescription drugs across a range of therapeutic areas. Founded in 1946 and incorporated in 1950, Kissei has built a reputation for its work in urology, nephrology, endocrinology, respiratory medicine and oncology. Through its dedicated in-house research centers, the company advances novel small molecules and biologic candidates from early discovery through clinical development.
The company’s product portfolio includes treatments for benign prostatic hyperplasia, chronic kidney disease, type 2 diabetes and various forms of cancer.
Featured Articles
- Five stocks we like better than Kissei Pharmaceutical
- Nano Nuclear’s Air Force Contract Puts Its Short-Squeeze Setup in Focus
- Amkor Sells Off After Earnings—Why Weak Guidance Isn’t the Real Story
- 5 Space Stocks Face a Brutal Correction: Which Ones Are Still Buys?
- Whirlpool’s Report May Show How Frozen the Housing Market Really Is
Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
